A tradition gets updated
Profile: Dedicated to excellence
by Jackie Vance
By Shelly Mesure
By Gary Tetz
Drugmakers Sanofi-Aventis U.S. Inc. and Sanofi-Aventis U.S. LCC will pay up to $109 million in a settlement over an alleged scheme to provide doctors with free units of its knee-injection drug Hyalgan in return for purchase of the treatment.